| 91126-3 |
Maximum clot strength amplitude.activator F induced |
Len |
Bld |
Pt |
Qn |
Thromboelastography.resonance |
|
ACTIVE |
Maximum amplitude activator F induced [Length] in Blood by Resonance TEG |
|
ADD |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
COAG |
|
91126-3 |
|
Thromboelastography.resonance |
|
|
Observation |
|
|
|
0 |
MA ActF Bld Res TEG |
|
|
|
|
|
ActF MA; Blood; COAGULATION; Hematology; Heme; Length; MA ActF; MA, ActF; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood |
2.65 |
2.65 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
| 91127-1 |
Maximum clot strength amplitude.adenosine diphosphate induced |
Len |
Bld |
Pt |
Qn |
Thromboelastography.resonance |
|
ACTIVE |
Maximum amplitude ADP induced [Length] in Blood by Resonance TEG |
|
ADD |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
COAG |
|
91127-1 |
|
Thromboelastography.resonance |
|
|
Observation |
|
|
|
0 |
MA ADP Bld Res TEG |
|
|
|
|
|
Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ADP MA; ANED; Blood; COAGULATION; Hematology; Heme; Length; MA ADP; MA, ADP; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood |
2.65 |
2.65 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
| 91128-9 |
Clot strength.platelet adenosine diphosphate receptor inhibited |
LenFr |
Bld |
Pt |
Qn |
Calculated |
|
ACTIVE |
Clot strength ADP receptor inhibited [Length fraction] in Blood by calculation |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
100 - [{(MAadp - MAactF) / (MAk - MAactF) } x 100], where MAadp, MAactF, and MAk are the maximum amplitude induced by adenosine diphosphate, activator F, and kaolin, respectively. |
|
|
|
COAG |
|
91128-9 |
|
Calculated |
|
|
Observation |
|
|
|
0 |
Clot strength ADP-R inhib LenFr Bld Calc |
|
|
|
|
|
Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ADP % inhibition; ANED; Blood; Calc; Calculation; Clot strength ADP-R inhib; COAGULATION; Hematology; Heme; Length Fraction; Medication stress; Percent; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Thrombocyte; Thrombocytes; WB; Whole blood |
2.7 |
2.65 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 91129-7 |
Clot strength.adenosine diphosphate induced |
LenFr |
Bld |
Pt |
Qn |
Calculated |
|
ACTIVE |
Clot strength ADP induced [Length fraction] in Blood by calculation |
|
MAJ |
DefinitionDescription |
|
|
% |
|
|
{(MAadp - MAactF) / (MAk - MAactF) } x 100, where MAadp, MAactF, and MAk are the maximum amplitude induced by adenosine diphosphate, activator F, and kaolin, respectively. |
|
|
|
COAG |
|
91129-7 |
|
Calculated |
|
|
Observation |
|
|
|
0 |
Clot strength ADP-ind LenFr Bld Res TEG |
|
|
|
|
|
Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ADP % aggregation; ANED; Blood; Calc; Calculation; Clot strength ADP induced; COAGULATION; Hematology; Heme; Length Fraction; Medication stress; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.65 |
|
|
|
|
|
|
|
% |
|
|
Release 2.70: METHOD_TYP: Updated from "Thromboelastography.resonance" because this result is a calculated value based on resonance TEG measurements but is not directly measured by resonance TEG; |
0 |
| 9113-2 |
Fluid output.biliary drain |
Vol |
Biliary tract |
Pt |
Qn |
|
|
ACTIVE |
Fluid output biliary drain |
|
MIN |
DefinitionDescription |
|
|
mL |
|
|
|
|
|
|
IO_OUT.MOLEC |
|
9113-2 |
|
|
|
|
|
|
|
|
0 |
Fluid output bile drain |
|
|
|
|
|
Fld; Fluid output bile drain; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume |
2.54 |
1.0i |
|
|
|
|
|
|
|
mL |
|
|
|
0 |
| 91130-5 |
Hantavirus RNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Hantavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91130-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Hantavirus RNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RS; Screen; SDA; SNV; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 91131-3 |
Rhinovirus RNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Rhinovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91131-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Rhinovirus RNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Rhino virus; RHV; Ribonucleic acid; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 91132-1 |
Measles virus RNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Measles virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91132-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
MeV RNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Lungs; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RS; Rubeola; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 91133-9 |
Respiratory syncytial virus RNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91133-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
RSV RNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RS; RSV; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 91134-7 |
Sexually transmitted pathogens panel |
- |
XXX |
Pt |
- |
Probe.amp.tar |
|
ACTIVE |
Sexually transmitted pathogens panel - Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
91134-7 |
|
Probe.amp.tar |
|
|
Order |
|
|
|
0 |
STI Pnl Spec NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; STI Pnl; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.73 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 91135-4 |
Acanthocytes |
PrThr |
Urine sed |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Acanthocytes [Presence] in Urine sediment by Light microscopy |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
91135-4 |
|
Microscopy.light |
|
|
Both |
|
|
|
0 |
Acanthocytes UrnS Ql Micro |
|
|
|
|
|
Acanthocyte; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Spur cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 91136-2 |
Lipoprotein metabolism panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Lipoprotein metabolism panel - Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
91136-2 |
|
|
|
|
Order |
|
|
|
0 |
Lipoprotein metabolism Pnl SerPl |
|
|
|
|
|
Chemistry; Lip; Lipoprot; Lipoprotein metabolism Pnl; Lipoproteins; LP; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 91137-0 |
ITPA gene.g.9330C>A |
Type |
Ser/Plas |
Pt |
Nom |
Molgen |
|
ACTIVE |
ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.PHARMG |
|
91137-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
ITPA g.9330C>A SerPl |
|
|
|
|
|
Genetics; Heredity; Heritable; Inherited; ITPA g.9330C>A; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Typ |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 91138-8 |
ITPA gene.g.9381A>C |
Type |
Ser/Plas |
Pt |
Nom |
Molgen |
|
ACTIVE |
ITPA gene g.9381A>C [Type] in Serum or Plasma by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.PHARMG |
|
91138-8 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
ITPA g.9381A>C SerPl |
|
|
|
|
|
Genetics; Heredity; Heritable; Inherited; ITPA g.9381A>C; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Typ |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 91139-6 |
Thiopurine methyltransferase activity panel |
- |
RBC |
Pt |
- |
|
|
ACTIVE |
Thiopurine methyltransferase activity panel - Red Blood Cells |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
91139-6 |
|
|
|
|
Order |
|
|
|
0 |
TPMT activity panel RBC |
|
|
|
|
|
Activ; Actvty; Chemistry; Erythrocytes; Methyl transferase; Movements; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Red blood cells; Red blood corpusles; TPMT; TPMT activity panel |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 9114-0 |
Fluid output.biliary drain |
VRat |
Biliary tract |
1H |
Qn |
|
|
ACTIVE |
Fluid output biliary drain 1 hour |
|
MIN |
DefinitionDescription |
|
|
mL/h |
|
|
|
|
|
|
IO_OUT.TIMED.MOLE |
|
9114-0 |
|
|
|
|
|
|
|
|
0 |
Fluid output bile drain 1h |
|
|
|
|
|
1 hour; 1.0Hr; 1HR; 60 min; 60 minutes; 60M; 60min; Fld; Flow; Fluid output bile drain; IO_OUTPUT; IO_OUTPUT.TIMED.MOLE; QNT; Quan; Quant; Quantitative; Volume Rate; vRate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL/h |
|
|
|
0 |
| 91140-4 |
Brucella sp Ab.IgG & IgM panel |
- |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Brucella sp IgG and IgM panel - Serum Qualitative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
91140-4 |
|
|
|
|
Order |
|
|
|
0 |
Brucella sp IgG+IgM Ser Ql |
|
|
|
|
|
Bruc; Brucella IgG+IgM Pnl; Brucellosis; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 91141-2 |
Thiopurine methyltransferase |
CCnc |
RBC |
Pt |
Qn |
Production of 6-Methylmercaptopurine |
|
ACTIVE |
TPMT activity in RBC by production of 6-MMP |
|
ADD |
DefinitionDescription |
|
|
nmol/mL/h |
|
|
|
|
|
|
CHEM |
|
91141-2 |
|
Production of 6-Methylmercaptopurine |
|
|
Observation |
|
|
|
0 |
TPMT RBC production of 6-MMP-cCnc |
|
|
|
|
|
Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MMP; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT |
2.65 |
2.65 |
|
|
|
|
|
|
|
nmol/mL/h |
|
|
|
0 |
| 91142-0 |
Thiopurine methyltransferase |
CCnc |
RBC |
Pt |
Qn |
Production of 6-Methylmercaptopurine riboside |
|
ACTIVE |
TPMT activity in RBC by production of 6-MMP riboside |
|
ADD |
DefinitionDescription |
|
|
nmol/mL/h |
|
|
|
|
|
|
CHEM |
|
91142-0 |
|
Production of 6-Methylmercaptopurine riboside |
|
|
Observation |
|
|
|
0 |
TPMT RBC production 6-MMP riboside-cCnc |
|
|
|
|
|
Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MMP; production of 6-MMP riboside; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT |
2.65 |
2.65 |
|
|
|
|
|
|
|
nmol/mL/h |
|
|
|
0 |
| 91143-8 |
Thiopurine methyltransferase |
CCnc |
RBC |
Pt |
Qn |
Production of 6-Methylthioguanine riboside |
|
ACTIVE |
TPMT activity in RBC by production of 6-MTG riboside |
|
ADD |
DefinitionDescription |
|
|
nmol/mL/h |
|
|
|
|
|
|
CHEM |
|
91143-8 |
|
Production of 6-Methylthioguanine riboside |
|
|
Observation |
|
|
|
0 |
TPMT RBC production 6-MTG riboside-cCnc |
|
|
|
|
|
Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MTG riboside; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT |
2.65 |
2.65 |
|
|
|
|
|
|
|
nmol/mL/h |
|
|
|
0 |
| 91144-6 |
Pregnancy prevention intention |
Find |
^Patient |
Pt |
Ord |
Reported |
|
ACTIVE |
Pregnancy prevention intention - Reported |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
91144-6 |
|
Reported |
|
|
Observation |
|
|
|
0 |
Preg prevention intention Reported |
|
|
|
|
|
Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Ordinal; P prime; Point in time; Preg prevention intention; Pregnancies; QL; Qual; Qualitative; Random; Screen |
2.66 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Updated Classtype from 1 (Lab) to 2 (Clinical) |
0 |
| 91145-3 |
What number best describes how pain has interfered with your enjoyment of life during the past W |
Find |
^Patient |
1W |
Ord |
|
|
ACTIVE |
What number best describes how pain has interfered with your enjoyment of life during the past week |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PEG |
|
91145-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 week; Finding; Findings; Last; No; Num; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.PEG |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 91146-1 |
What number best describes how pain has interfered with your general activity during the past W |
Find |
^Patient |
1W |
Ord |
|
|
ACTIVE |
What number best describes how pain has interfered with your general activity during the past week |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PEG |
|
91146-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 week; Activ; Actvty; Finding; Findings; Last; Movements; No; Num; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.PEG |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 91147-9 |
Mean score |
Score |
^Patient |
Pt |
Qn |
Pain intensity, Enjoyment of life, General activity (PEG) |
|
ACTIVE |
Mean score [PEG] |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
SURVEY.PEG |
|
91147-9 |
|
Pain intensity, Enjoyment of life, General activity (PEG) |
|
|
Both |
|
|
|
0 |
|
|
|
|
|
|
Activ; Actvty; Average; Avg; Point in time; Polyethylene Glycol; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PEG |
2.65 |
2.65 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
| 91148-7 |
Pain intensity, Enjoyment of life, General activity scale |
- |
^Patient |
Pt |
- |
Pain intensity, Enjoyment of life, General activity (PEG) |
|
ACTIVE |
Pain intensity, Enjoyment of life, General activity scale [PEG] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.GNHLTH |
|
91148-7 |
|
Pain intensity, Enjoyment of life, General activity (PEG) |
|
|
Order |
|
|
|
0 |
|
|
|
Pain intensity, Enjoyment of life, General activity (PEG) 3 item pain scale |
|
|
Activ; Actvty; Movements; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEG scale; Pnl; Point in time; Polyethylene Glycol; Random; Survey; SURVEY.GNHLTH |
2.7 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
